Skip to main content
MedicHelpLine
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsORALGeneric

RANICLOR

CEFACLOR

Standard Dose
EQ 250MG BASE
Max Dose
Refer to approved labeling
Primary Use
Marketing status: Discontinued
Summary

Approval overview RANICLOR is listed in Drugs@FDA under application 065092 (ANDA).

Marketing status: Discontinued Active ingredient CEFACLOR Form and strength TABLET, CHEWABLE;ORAL - EQ 250MG BASE Sponsor RANBAXY LABS LTD Submission history Latest submission status date: 2003-12-22 00:00:00.

Structured Monograph

Clinical summary

Approval overview RANICLOR is listed in Drugs@FDA under application 065092 (ANDA). Marketing status: Discontinued Active ingredient CEFACLOR Form and strength TABLET, CHEWABLE;ORAL - EQ 250MG BASE Sponsor RANBAXY LABS LTD Submission history Latest submission status date: 2003-12-22 00:00:00. Submission type: ORIG.

Monitoring

  • Marketing status: Discontinued

Interaction Notes

  • No interaction notes stored yet.
RANICLOR (CEFACLOR) | Drug Monograph | MedicHelpline